Crinetics Pharmaceuticals, Inc.
CRNX
$35.70
-$0.35-0.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.90% | -8.70% | -6.10% | -5.90% | 56.96% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -37.37% | 39.60% | 288.80% | -74.79% | 241.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00% | -88.56% | 773.80% | -73.40% |
| Total Current Assets | -6.50% | -7.89% | -5.72% | -6.13% | 56.72% |
|
|
|||||
| Total Current Assets | -6.50% | -7.89% | -5.72% | -6.13% | 56.72% |
| Net Property, Plant & Equipment | -1.33% | -1.85% | 2.26% | -0.46% | -0.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.85% | 22.20% | 21.53% | 256.85% | 100.39% |
| Total Assets | -5.83% | -7.25% | -5.27% | -5.11% | 53.04% |
|
|
|||||
| Total Accounts Payable | 270.13% | -46.06% | 15.07% | 68.15% | 18.51% |
| Total Accrued Expenses | -8.72% | 23.49% | 26.52% | -13.76% | 13.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.75% | -2.56% | -3.97% | -3.76% | -3.52% |
| Total Finance Division Other Current Liabilities | -24.79% | -13.76% | -13.69% | 1.38% | 12.98% |
| Total Other Current Liabilities | -24.79% | -13.76% | -13.69% | 1.38% | 12.98% |
| Total Current Liabilities | 14.72% | 8.42% | 19.34% | -3.98% | 11.43% |
|
|
|||||
| Total Current Liabilities | 14.72% | 8.42% | 19.34% | -3.98% | 11.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.52% | -1.44% | -1.39% | -1.42% | -1.23% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.66% | 10.72% | 4.05% | 9.89% | -3.03% |
| Total Liabilities | 8.33% | 4.93% | 9.99% | -2.24% | 5.17% |
|
|
|||||
| Common Stock & APIC | 1.82% | 1.29% | 1.46% | 1.10% | 33.69% |
| Retained Earnings | -9.49% | -11.17% | -11.02% | -10.16% | -9.25% |
| Treasury Stock & Other | -15.80% | 37.97% | -24.63% | 107.89% | -52.75% |
| Total Common Equity | -7.47% | -8.48% | -6.58% | -5.34% | 59.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.47% | -8.48% | -6.58% | -5.34% | 59.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.47% | -8.48% | -6.58% | -5.34% | 59.04% |
|
|
|||||